| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHDERM.139.4.467 |
| P953 | full work available at URL | http://jamanetwork.com/journals/jamadermatology/fullarticle/479277 |
| P698 | PubMed publication ID | 12707094 |
| P5875 | ResearchGate publication ID | 10794506 |
| P2093 | author name string | Daniel Roling | |
| David J. Margolis | |||
| James J. Leyden | |||
| Eric Y. Huang | |||
| Ross M. Levy | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| dermatology | Q171171 | ||
| P304 | page(s) | 467-471 | |
| P577 | publication date | 2003-04-01 | |
| P1433 | published in | Archives of Dermatology | Q15749524 |
| P1476 | title | Effect of antibiotics on the oropharyngeal flora in patients with acne | |
| Effect of Antibiotics on the Oropharyngeal Flora in Patients With Acne | |||
| P478 | volume | 139 |
| Q34074114 | A Three-Step Acne System Containing Solubilized Benzoyl Peroxide versus Benzoyl Peroxide/Clindamycin in Pediatric Patients with Acne |
| Q26752267 | A systematic review and meta-analysis on Staphylococcus aureus carriage in psoriasis, acne and rosacea |
| Q38010519 | Antibiotic overuse and resistance in dermatology |
| Q53756862 | Antibiotics and acne: an emerging iceberg of antibiotic resistance? |
| Q35571602 | Antibiotics, acne, and Staphylococcus aureus colonization |
| Q57184892 | Approaches to limit systemic antibiotic use in acne: Systemic alternatives, emerging topical therapies, dietary modification, and laser and light-based treatments |
| Q36903984 | Association of pharyngitis with oral antibiotic use for the treatment of acne: a cross-sectional and prospective cohort study. |
| Q36024801 | Canadian Clinical Practice Guidelines for Rosacea |
| Q34636056 | European evidence-based (S3) guidelines for the treatment of acne. |
| Q35194210 | Evaluation of nasal and oropharyngeal flora in patients with acne vulgaris according to treatment options |
| Q37337392 | Inhibition of propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius |
| Q49488118 | Managing acne in the Middle East: consensus recommendations |
| Q43766645 | New antibiotic therapies for acne and rosacea |
| Q28078835 | Optimizing Non-Antibiotic Treatments for Patients with Acne: A Review |
| Q40460269 | Prevalence of Streptococcus pyogenes as an oropharynx colonizer in children attending daycare: a comparative study of different regions in Brazil. |
| Q90419978 | Propionibacterium (Cutibacterium) acnes Bacteriophage Therapy in Acne: Current Evidence and Future Perspectives |
| Q37629864 | Prospects of Phage Application in the Treatment of Acne Caused by Propionibacterium acnes |
| Q35714222 | South-East Asia study alliance guidelines on the management of acne vulgaris in South-East Asian patients |
| Q33715142 | Spironolactone for the treatment of acne in women, a retrospective study of 110 patients |
| Q36982661 | Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: Part 1: Antibiotic Prescribing Patterns, Sources of Antibiotic Exposure, Antibiotic Consumption and Emergence of Antibiotic Resistance |
| Q94416599 | Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: Part 2: Perspectives on Antibiotic Use and the Microbiome and Review of Microbiologic Effects of Selected Specific Therapeutic Agents |
| Q35606925 | Subantimicrobial dose doxycycline for acne and rosacea |
| Q34512706 | Systematic review of antibiotic resistance in acne: an increasing topical and oral threat |
| Q36607558 | Systemic antibiotic therapy of acne vulgaris |
| Q43927439 | The epidemiology and comorbidities of severe acne in children aged 0-17 years |
| Q26767243 | The epidemiology of acne vulgaris in late adolescence |
| Q39311767 | The management of acne vulgaris in primary care: a cohort study of consulting and prescribing patterns using the Clinical Practice Research Datalink |
| Q27005460 | The skin microbiome: potential for novel diagnostic and therapeutic approaches to cutaneous disease |
| Q64132414 | Trends in Oral Antibiotic Prescription in Dermatology, 2008 to 2016 |
| Q92067394 | Use of Antibiotics for Dermatologic Procedures From 2008 to 2016 |
Search more.